Nordwand Advisors’s Vivos Therapeutics VVOS Stock Holding History
Bought
Maintained
Sold
Other funds holding VVOS
Nordwand Advisors's VVOS Position: Q3 2026 in Review
Nordwand Advisors opened a new position in Vivos Therapeutics (VVOS) in Q3 2026: 10,000 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #145 among its holdings.
27 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.
- Nordwand Advisors held 10,000 shares of Vivos Therapeutics worth $1.48K as of Q3 2026.
- Vivos Therapeutics was a new Nordwand Advisors position in Q3 2026.
- Vivos Therapeutics made up ﹤0.01% of Nordwand Advisors's portfolio in Q3 2026, its #145 holding.
- 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.
Based on Nordwand Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.